Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pig breeding and respiratory syndrome NVDC-JXA1 strain-porcine parvovirus disease duplex inactivated vaccine and preparation method and application thereof

A technology of NVDC-JXA1, double inactivated vaccine, applied in antiviral agents, viral antigen components, pharmaceutical formulations, etc., can solve problems such as the misery of pig farm operators, the mutual interference of vaccines and vaccines, and the inability to meet immunization needs. , to achieve the effect of being easy to popularize and apply, the preparation method is simple and easy to operate, and the immune density and the cost of vaccines are reduced

Inactive Publication Date: 2012-10-10
GUANGDONG DAHUANONG ANIMAL HEALTH PRODS +1
View PDF4 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Because there is only a single vaccine available on the market at present, to prevent these two diseases at the same time, pigs of the same age group often need to be immunized with 2 injections, which increases the immune density of pigs of each age group, while the cost of vaccines and the cost of injection Manpower and stress on pigs, as well as short-term high-density injections cause mutual interference between vaccines, making pig farm operators miserable
With the development of my country's intensive pig industry, traditional monovalent vaccines can no longer meet the needs of immunity, and there is an urgent need for a vaccine that can prevent multiple diseases with one shot; therefore, in order to meet the epidemic prevention needs of the pig industry, a safe, stable and capable Porcine Reproductive and Respiratory Syndrome-Porcine Parvovirus Dual Inactivated Vaccine with "One Injection to Prevent Two Diseases" is Urgent and Important

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0034] A preparation method of porcine reproductive and respiratory syndrome NVDC-JXA1 strain-porcine parvovirus disease dual inactivated vaccine, which comprises the following steps:

[0035]1) Preparation of porcine reproductive and respiratory syndrome virus liquid: inoculate Marc-145 cells that have grown into a single layer with 5% volume ratio of porcine reproductive and respiratory syndrome virus NVDC-JXA1 strain, rotate culture, when 70% When the above cells have cytopathic changes, harvest the porcine reproductive and respiratory syndrome virus-infected cell culture medium, freeze and thaw, remove cell debris by centrifugation or filtration, then inactivate with formaldehyde solution, and then concentrate and concentrate to the original volume by ultrafiltration half of the concentrated porcine reproductive and respiratory syndrome virus liquid;

[0036] 2) Preparation of porcine parvovirus liquid: using the method of synchronous inoculation, while the ST cells are su...

Embodiment 1

[0042] A preparation of porcine reproductive and respiratory syndrome NVDC-JXA1 strain-porcine parvovirus disease dual inactivated vaccine is carried out according to the following steps: 1) the volume ratio of porcine reproductive and respiratory syndrome virus NVDC-JXA1 strain is 5% Inoculate the Marc-145 cells that have grown into a single layer, and rotate them at 37°C at a speed of 8 rpm. When more than 70% of the cells show cytopathic changes, harvest the culture medium of porcine reproductive and respiratory syndrome virus-infected cells, freeze-thaw Twice, remove cell debris by centrifugation or filtration, then inactivate with formaldehyde solution with a final concentration of 0.1% at 37°C for 18 hours, and then concentrate by ultrafiltration to half of the original volume to obtain concentrated porcine reproductive and respiratory syndrome virus liquid ; 2) Using the method of synchronous inoculation, when the ST cells are subcultured in separate bottles, the porcine...

Embodiment 2

[0044] A preparation of porcine reproductive and respiratory syndrome NVDC-JXA1 strain-porcine parvovirus disease dual inactivated vaccine is carried out according to the following steps: 1) the volume ratio of porcine reproductive and respiratory syndrome virus NVDC-JXA1 strain is 5% Inoculate the Marc-145 cells that have grown into a monolayer, and rotate at 37°C at a speed of 9 rpm. When more than 70% of the cells show cytopathic changes, harvest the culture medium of porcine reproductive and respiratory syndrome virus-infected cells, freeze-thaw Twice, remove cell debris by centrifugation or filtration, then inactivate with formaldehyde solution with a final concentration of 0.1% at 37°C for 18 hours, and then concentrate by ultrafiltration to half of the original volume to obtain concentrated porcine reproductive and respiratory syndrome virus liquid ; 2) Using the method of synchronous inoculation, when the ST cells are subcultured in separate bottles, the porcine parvovi...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention particularly relates to a pig breeding and respiratory syndrome NVDC-JXA1 strain-porcine parvovirus disease duplex inactivated vaccine and a preparation method and application thereof. The pig breeding and respiratory syndrome NVDC-JXA1 strain-porcine parvovirus disease duplex inactivated vaccine is prepared by enabling pig breeding and respiratory syndrome virus NVDC-JXA1 strain to inoculate with a Marc-145 cell, enabling a porcine parvovirus virulent strain to inoculate with an ST cell, respectively obtaining infection cell culture fluid to be inactivated by using formaldehyde solution, and conducting ultrafiltration, concentration and mixing to obtain mixed virus liquid to be mixed and emulsified with oil adjuvant. The inactivated vaccine comprises, by weight, 1-2 parts of the oil adjuvant and 1 part of mixed virus liquid aqueous phase, the inactivated vaccine is prepared by preparing pig breeding and respiratory syndrome virus liquid, porcine parvovirus liquid, an oil phase, the aqueous phase and emulsifying, and NVDC-JXA1 strain pig breeding and respiratory syndrome-porcine parvovirus disease duplex inactivated vaccine quality standards are built.

Description

[0001] technical field [0002] The invention relates to the technical field of veterinary biological products, in particular to a porcine reproductive and respiratory syndrome NVDC-JXA1 strain-porcine parvovirus dual inactivated vaccine and a preparation method and application thereof. [0003] Background technique [0004] Porcine reproductive and respiratory syndrome (PRRS), also known as blue ear disease, is a highly contagious infectious disease of pigs caused by porcine reproductive and respiratory syndrome virus (PRRSV). Infection, but pregnant sows and piglets under 1 month of age are most susceptible. The disease is mainly characterized by miscarriage, stillbirth, weak fetus, mummified fetus, dyspnea, sepsis and high mortality in piglets. Since there is no specific drug for the treatment of the disease, the use of specific vaccines has become the main measure for the prevention and control of PRRS. At present, two types of vaccines, inactivated vaccine and attenu...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K39/295A61P31/14A61P31/20A61K39/12A61K39/23
Inventor 陈瑞爱田克恭练炳洲遇秀琳唐满华翟新验邓小熊周智林绮萍曲萍
Owner GUANGDONG DAHUANONG ANIMAL HEALTH PRODS
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products